Ancillary techniques on direct-smear aspirate slides a significant evolution for cytopathology techniques

Cancer Cytopathology

Volumn 121, Issue 3, 2013, Pages 120-128

  Knoepp, Stewart M ^a   Roh, Michael H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cancer; Cell block; Cytology; Direct smear; Fine needle aspiration; Immunocytochemistry; Molecular; Personalized medicine; Polymerase chain reaction

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; B RAF KINASE; CISPLATIN; CRIZOTINIB; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GEMCITABINE; K RAS PROTEIN; PEMETREXED; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN RET; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR PAX8; VEMURAFENIB;

ASPIRATION CYTOLOGY; BREAST CANCER; CANCER CLASSIFICATION; CELL STRUCTURE; COST EFFECTIVENESS ANALYSIS; CYTOGENETICS; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC VALUE; FILTER; FINE NEEDLE ASPIRATION BIOPSY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FROZEN SECTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MELANOMA; NEEDLE BIOPSY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TISSUE PRESERVATION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL;

CARCINOMA, NON-SMALL-CELL LUNG; CYTODIAGNOSIS; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; LUNG NEOPLASMS; MELANOMA; PANCREATIC NEOPLASMS;

EID: 84876269662     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21214     Document Type: Review

References (36)

1. Clark DP. Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions. Cancer. 2009;117:289-297.
2. Krishnamurthy S. Applications of molecular techniques to fine-needle aspiration biopsy. Cancer. 2007;111:106-122. (Pubitemid 46655642)
3. Shin HJ, Thorson P, Gu J, Katz RL. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization. Diagn Cytopathol. 2003;29:61-66. (Pubitemid 36988080)
4. Aiello A, Delia D, Giardini R, et al. PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal. Diagn Mol Pathol. 1997;6:154-160. (Pubitemid 27423840)
5. Bentz JS, Rowe LR, Anderson SR, Gupta PK, McGrath CM. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material. Cancer. 2004;102:124-131. (Pubitemid 38489970)
6. Caraway NP, Gu J, Lin P, Romaguera JE, Glassman A, Katz R. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005;105:110-118. (Pubitemid 40604945)
7. Stelow EB, Policarpio-Nicolas ML, Sudduth KW, LeGallo RD. Burkitt lymphoma. Diagn Cytopathol. 2008;36:172-173. (Pubitemid 351312132)
8. Gautam U, Srinivasan R, Rajwanshi A, Bansal D, Marwaha RK, Vasishtha RK. Reverse transcriptase-polymerase chain reaction as an ancillary molecular technique in the diagnosis of small blue round cell tumors by fine-needle aspiration cytology. Am J Clin Pathol. 2010;133:633-645.
9. Roh MH, Dal Cin P, Silverman SG, Cibas ES. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms. Cancer (Cancer Cytopathol). 2010;118:137-145.
10. Caraway NP, Katz RL. A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer (Cancer Cytopathol). 2010;118:175-183.
11. Bofin AM, Ytterhus B, Martin C, O'Leary JJ, Hagmar BM. Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma. Am J Clin Pathol. 2004;122:110-119. (Pubitemid 38849881)
12. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111:508-516. (Pubitemid 350304903)
13. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid. 2009;19:1351-1361.
14. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.
15. Cantara S, Capezzone M, Marchisotta S, et al. Impact of protooncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab. 2010;95:1365-1369.
16. Moses W, Weng J, Sansano I, et al. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg. 2010;34:2589-2594.
17. Ohori NP, Nikiforova MN, Schoedel KE, et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer (Cancer Cytopathol). 2010;118:17-23.
18. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26:3543-3551.
19. Rekhtman N, Brandt SM, Sigel CS, et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol. 2011;6:451-458.
20. Mino-Kenudson M, Mark EJ. Reflex testing for epidermal growth factor receptor mutation and anaplastic lymphoma kinase fluorescence in situ hybridization in non-small cell lung cancer. Arch Pathol Lab Med. 2011;135:655-664.
21. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35:15-25.
22. Arkenau HT, Kefford R, Long GV. Targeting BRAF for patients with melanoma. Br J Cancer. 2011;104:392-398.
23. Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010; 363:809-819.
24. Long GV, Menzies AM, Nagrial AM, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol. 2011;29:1239-1246.
25. Hookim K, Roh MH, Willman J, et al. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma. Cancer (Cancer Cytopathol). 2012;120:52-61.
26. Betz BL, Roh MH, Weigelin HC, et al. The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma. Am J Clin Pathol. 2011;136:564-571.
27. da Cunha Santos G, Liu N, Tsao MS, Kamel-Reid S, Chin K, Geddie WR. Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards: is this the tool for biobanking cytological samples in the molecular era? Cancer (Cancer Cytopathol). 2010;118:450-456.
28. Ladd AC, O'Sullivan-Mejia E, Lea T, et al. Preservation of fineneedle aspiration specimens for future use in RNA-based molecular testing. Cancer (Cancer Cytopathol). 2011;119:102-110.
29. Killian JK, Walker RL, Suuriniemi M, et al. Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling. J Mol Diagn. 2010;12:739-745.
30. Roh MH, Schmidt L, Placido J, et al. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma [published online ahead of print April 15, 2011]. Diagn Cytopathol. doi: 10.1002/dc.21680.
31. Knoepp SM, Hookim K, Placido J, Fields KL, Roh MH. The application of immunocytochemistry to cytologic direct smears of metastatic merkel cell carcinoma [published online ahead of print December 5, 2011]. Diagn Cytopathol. doi: 10.1002/dc.22807.
32. Knoepp SM, Placido J, Fields KL, Thomas D, Roh MH. The application of immunocytochemistry to direct smears in the diagnosis of effusions [published online ahead of print April 30, 2012]. Diagn Cytopathol. doi: 10.1002/dc.22852.
33. Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer (Cancer Cytopathol). 2011;119:111-117.
34. da Cunha Santos G, SaiegMA, GeddieW, Leighl N. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities. Cancer (Cancer Cytopathol). 2011;119:80-91.
35. van Eijk R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One. 2011;6:e17791.
36. Smith GD, Chadwick BE, Willmore-Payne C, Bentz JS. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis. J Clin Pathol. 2008;61:487-493. (Pubitemid 351518232)